Search Results - "CUSI, G"

Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro by Correale, P., Botta, C., Cusi, M.G., Del Vecchio, M.T., De Santi, M.M., Gori Savellini, G., Bestoso, E., Apollinari, S., Mannucci, S., Marra, M., Abbruzzese, A., Aquino, A., Turriziani, M., Bonmassar, L., Caraglia, M., Tagliaferri, P.

“…Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor receptor, approved for colorectal carcinoma treatment in…”
Get full text

Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection by Ambrosio, Maria R, De Falco, Giulia, Gozzetti, Alessandro, Rocca, Bruno J, Amato, Teresa, Mourmouras, Vasileios, Gazaneo, Sara, Mundo, Lucia, Candi, Veronica, Piccaluga, Pier P, Cusi, Maria G, Leoncini, Lorenzo, Lazzi, Stefano

Get full text

Testicular involvement during Toscana virus infection: an unusual manifestation? by Zanelli, G., Bianco, C., Cusi, M. G.

Get full text

Age-Dependent Seroprevalence of Toscana Virus in Central Italy and Correlation with the Clinical Profile by Terrosi, C, Olivieri, R, Bianco, C, Cellesi, C, Cusi, M G

“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients by Martino, EC, Misso, G, Pastina, P, Costantini, S, Vanni, F, Gandolfo, C, Botta, C, Capone, F, Lombardi, A, Pirtoli, L, Tassone, P, Ulivieri, C, Tagliaferri, P, Cusi, MG, Caraglia, M, Correale, P

“…The mPEBev is an anticancer regimen which combines a chemotherapy doublet, based on cisplatin and oral etoposide (mPE), with bevacizumab (mPEBev), a mAb…”
Get full text

Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis by Annunziata, P, Cioni, C, Cantalupo, L, Di Genova, G, Savellini, G. Gori, Cusi, G

“…Abstract High intrathecal levels of anti-myelin basic protein (MBP) IgM were previously found to be significantly associated with early favorable course in a…”
Get full text

Humoral immunity to respiratory syncytial virus in young and elderly adults by TERROSI, C., Di GENOVA, G., MARTORELLI, B., VALENTINI, M., CUSI, M. G.

“…Respiratory syncytial virus (RSV) has been demonstrated to cause substantial disease in elderly and immunocompromised subjects. The relationship of serum…”
Get full text

Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis by Rossi, Matteo, Castiglioni, Patrik, Hartley, Mary-Anne, Eren, Remzi Onur, Prével, Florence, Desponds, Chantal, Utzschneider, Daniel T., Zehn, Dietmar, Cusi, Maria G., Kuhlmann, F. Matthew, Beverley, Stephen M., Ronet, Catherine, Fasel, Nicolas

“…The presence of the endogenous Leishmania RNA virus 1 (LRV1) replicating stably within some parasite species has been associated with the development of more…”
Get full text

T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 by MASIERO, S, DEL VECCHIO, C, PAROLIN, C, GAVIOLI, R, MATTIUZZO, G, CUSI, M. G, MICHELI, L, GENNARI, F, SICCARDI, A, MARASCO, W. A, PALU, G

“…Immune-based approaches of cell therapy against viral pathogens such as the human immunodeficiency virus type 1 (HIV-1) could be of primary importance for the…”
Get full text

SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines by Di Giacomo, Anna M., Giacobini, Gianluca, Anichini, Gabriele, Gandolfo, Claudia, D'alonzo, Vincenzo, Calabrò, Luana, Lofiego, Maria F., Cusi, Maria G., Maio, Michele

“…The protective role against SARS-CoV-2 infection by the third booster dose of mRNA vaccines in cancer patients with solid malignancies is presently unknown. We…”
Get full text

Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: Children and elderly by Sastre, P., Cusi, M.G., Manoha, C., Schildgen, O., Ruiz, T., Vela, C., Rueda, P.

“…Human respiratory syncytial virus (hRSV) is the main viral cause of severe respiratory infections in children and a common cause of morbidity in the elderly…”
Get full text

Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix by Di Giacomo, Anna M., Giacobini, Gianluca, Gandolfo, Claudia, Lofiego, Maria F., Cusi, Maria G., Maio, Michele

Get full text

Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers by Giani, Tommaso, Arena, Fabio, Pollini, Simona, Di Pilato, Vincenzo, D'Andrea, Marco Maria, Henrici De Angelis, Lucia, Bassetti, Matteo, Rossolini, Gian Maria

“…Pseudomonas aeruginosa is a major cause of severe healthcare-associated infections and often shows MDR phenotypes. Ceftolozane/tazobactam is a new…”
Get full text

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity by Cusi, M.G, Zurbriggen, R, Correale, P, Valassina, M, Terrosi, C, Pergola, L, Valensin, P.E, Glück, R

“…In the present study we investigated the efficacy of a new potential vaccine constituted of the respiratory syncytial virus (RSV)-F protein associated with…”
Get full text

Immunological characterization of respiratory syncytial virus N protein epitopes recognized by human cytotoxic T lymphocytes by Terrosi, Chiara, Di Genova, Giuseppa, Savellini, Gianni Gori, Correale, Pierpaolo, Blardi, Patrizia, Cusi, Maria G

“…Virus-specific cytotoxic T lymphocytes (CTLs) are crucial for the control of respiratory syncytial virus (RSV) infection. This study has identified CTL…”
Get full text

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2: results from a phase Ib clinical trial by Correale, P, Campoccia, G, Tsang, K.Y, Micheli, L, Cusi, M.G, Sabatino, M, Bruni, G, Sestini, S, Petrioli, R, Pozzessere, D, Marsili, S, Fanetti, G, Giorgi, G, Francini, G

“…Experimental findings suggest that granulocyte-monocyte-colony stimulating factor (GM-CSF) synergistically interacts with interleukin-2 (IL-2) in generating an…”
Get full text

Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only by FIGURA, N, GUGLIELMETTI, P, ROSSOLINI, A, BARBERI, A, CUSI, G, MUSMANNO, R. A, RUSSI, M, QUARANTA, S

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes by Correale, P, Cusi, M.G, Sabatino, M, Micheli, L, Pozzessere, D, Nencini, C, Valensin, P.E, Petrioli, R, Giorgi, G, Zurbriggen, R, Gluck, R, Francini, G

“…We investigated influenza virosomes as a TAA-gene delivery system for use in TAA-directed anti-cancer vaccine therapy. An engineered plasmid (GC90) expressing…”
Get full text

Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trial by Correale, Pierpaolo, Botta, Cirino, Rotundo, Maria S, Guglielmo, Annamaria, Conca, Raffaele, Licchetta, Antonella, Pastina, Pierpaolo, Bestoso, Elena, Ciliberto, Domenico, Cusi, Maria G, Fioravanti, Antonella, Guidelli, Giacomo M, Bianco, Maria T, Misso, Gabriella, Martino, Elodia, Caraglia, Michele, Tassone, Pierfrancesco, Mini, Enrico, Mantovani, Giovanni, Ridolfi, Ruggero, Pirtoli, Luigi, Tagliaferri, Pierosandro

“…The GOLFIG-2 phase III trial was designed to compare the immunobiological activity and antitumor efficacy of GOLFIG chemoimmunotherapy regimen with standard…”
Get full text

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response by Botta, C, Misso, G, Martino, E C, Pirtoli, L, Cusi, M G, Tassone, P, Tagliaferri, P, Caraglia, M, Correale, P

“…Even though the crucial role played by inflammation in cancer development and progression was first hypothesized by Rudolf Virchow at the beginning of the…”
Get full text